INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update
The Board of International Biotechnology Trust plc (the 'Company') notes the following change to the value of an unquoted portfolio company, Entellus.
The Directors' valuation of the holding in this unquoted portfolio company has been decreased today from £0.9m ($1.5m) to £0.8m ($1.2m) to reflect the company's acceptance of an externally priced term sheet to raise further funding. This valuation change will be incorporated into the net asset value ('NAV') of the Company from today and reflected in the Company's NAV announcements with effect from Tuesday, 29 September 2009. The impact on the NAV will be a reduction of 0.2p per share based on today's released NAV.
Enquiries:
Kate Bingham/David Pinniger
Telephone: 020 7412 7070
SV Life Sciences Managers LLP
Investment Manager
Rachael Nelson
Telephone: 020 7410 3132
BNP Paribas Secretarial Services Limited
Company Secretary
28 September 2009